ABDNAZ Synthesis via Aqueous Extraction and Crystallization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods for synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine (ABDNAZ) result in low purity and yield, and involve handling explosive intermediates that are sensitive to impact and friction, making the process hazardous and inefficient for pharmaceutical applications.
Innovation Solution
A method involving the reaction of 1-tert-butyl-3,3-dinitroazetidine (DNAZ) with bromoacetyl bromide and boron trifluoride etherate in a solvent, followed by aqueous extraction and crystallization, which separates and recovers ABDNAZ with higher purity and yield, eliminating the need to handle solid explosive intermediates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If the Bednarski process is used to synthesize ABDNAZ, then ABDNAZ can be produced at a reasonable yield of approximately 75%, but the purity is only approximately 98% which is not sufficient for pharmaceutical uses
Solution Approach 1:
The patent applies extraction by dissolving the reaction mixture in water to separate DNAZ HBr into the aqueous phase, then extracting ABDNAZ into an organic phase using dichloromethane. This multi-phase extraction process removes impurities and achieves pharmaceutical-grade purity while maintaining high yield through efficient phase separation and selective solubility.
2Ease of manufacture
If the Bednarski process is used to synthesize ABDNAZ, then the process can be completed with conventional equipment, but solid DNAZ HBr intermediate must be handled carefully as it is sensitive to impact, friction, and other external stimuli
Solution Approach 1:
The patent changes the physical state parameter of DNAZ HBr from solid to dissolved state by performing the reaction and workup in aqueous solution. This parameter change eliminates the hazardous solid explosive intermediate while maintaining process simplicity, as the DNAZ HBr remains dissolved and can be safely separated through phase extraction rather than requiring careful handling of solid material.
3Manufacturing precision
If the Bednarski process is used to synthesize ABDNAZ, then the process can be completed in fewer steps, but multiple washing and drying steps are required to achieve sufficient purity
Solution Approach 1:
The patent uses water as an intermediary solvent to dissolve DNAZ HBr and separate it from ABDNAZ through phase extraction. This intermediary approach allows for efficient separation in a single aqueous extraction step followed by organic phase extraction, eliminating the need for multiple washing and drying steps while achieving pharmaceutical-grade purity through the selective solubility and phase separation mechanism.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method produces ABDNAZ with a purity of greater than 99.5% and a yield of 80-100%, significantly reducing hazards and process complexity, while using conventional equipment and facilities, making it suitable for pharmaceutical use.
Implementation Method 1
DNAZ HBr is water soluble and, therefore, can be separated from ABDNAZ by dissolving the reaction mixture in water and extracting ABDNAZ into an organic phase
Implementation Method 2
extracting ABDNAZ into an organic phase
Implementation Method 3
The organic phase is separated from the aqueous phase and ethanol is added to the organic phase comprising the dichloromethane and the ABDNAZ. The dichloromethane is evaporated under reduced pressure to form an ABDNAZ/ethanol suspension.
Data Source
Figure 1~2
Figure 3
AI summary
A method of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine (ABDNAZ) by reacting DNAZ with bromoacetyl bromide and boron trifluoride etherate in a solvent to produce a mixture comprising ABDNAZ and a salt of DNAZ. Water and an additional volume of the solvent are added to the mixture to form an organic phase comprising the ABDNAZ and an aqueous phase comprising the salt of DNAZ. The organic phase and the aqueous phase are separated to produce an ABDNAZ/solvent solution comprising the ABDNAZ and the aqueous phase comprising the salt of DNAZ. A nonsolvent is added to the ABDNAZ/solvent solution to produce an ABDNAZ/solvent/nonsolvent mixture. The ABDNAZ is subsequently recovered. A composition comprising ABDNAZ is also disclosed.